✦ LIBER ✦

1108 SELECTION OF HCV GENOTYPE 1 PATIENTS FOR DUAL THERAPY WITH PEGINTERFERON ALFA-2A/RIBAVIRIN WITH A HIGH PROBABILITY OF SUSTAINED VIROLOGIC RESPONSE ACCORDING TO BASELINE CHARACTERISTICS ALONE

✍ Scribed by Ferenci, P.; Aires, R.; Ancuta, I.; Arohnson, A.; Cheinquer, H.; Delic, D.; Gschwantler, M.; Larrey, D.; Tallarico, L.; Schmitz, M.; Tatsch, F.; Ouzan, D.

Book ID: 122859574
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 64 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61120-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A tool for selecting patients with a hig

A tool for selecting patients with a high probability of sustained virological response to peginterferon alfa-2a (40kD)/ribavirin

✍ Ferenci, Peter; Aires, Rodrigo; Ancuta, Ioan; Arohnson, Andrew; Cheinquer, Hugo; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

Mutation frequency of NS5A in patients v

Mutation frequency of NS5A in patients vertically infected with HCV genotype 1 predicts sustained virological response to peginterferon alfa-2b and ribavirin combination therapy

✍ A. C. W. Jenke; S. Moser; V. Orth; M. Zilbauer; P. Gerner; S. Wirth 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

828 TREATMENT WITH PEGINTERFERON ALFA-2A

828 TREATMENT WITH PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN IN OLDER HCV GENOTYPE 1 PATIENTS WITH POSITIVE PROGNOSTIC FACTORS LEADS TO HIGH RATES OF SUSTAINED VIROLOGICAL RESPONSE

✍ K.R. Reddy; D. Messinger; M. Popescu; S.J. Hadziyannis 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONS

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R

✍ M.S. Sulkowski; M. Bourliere; J.-P. Bronowicki; A. Streinu-Cercel; L. Preotescu; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONS

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

✍ M.S. Sulkowski; E. Ceasu; T. Asselah; F.A. Caruntu; J. Lalezari; P. Ferenci; A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Factors associated with rapid and early

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population

✍ M. Rodriguez-Torres; M. S. Sulkowski; R. T. Chung; F. M. Hamzeh; D. M. Jensen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB